Russell Investments Group, Ltd. Y M Abs Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$11.6 - $17.25 $1,890 - $2,811	163 Added 652.0%	188 $2,000
Q1 2024 May 08, 2024	SELL	$6.57 - $18.69 $111,052 - $315,917	-16,903 Reduced 99.85%	25 $0
Q4 2023 Feb 05, 2024	SELL	$4.88 - $7.42 $47,458 - $72,159	-9,725 Reduced 36.49%	16,928 $115,000
Q3 2023 Nov 13, 2023	SELL	$4.86 - $7.23 $7,644 - $11,372	-1,573 Reduced 5.57%	26,653 $145,000
Q2 2023 Aug 10, 2023	BUY	$5.68 - $10.34 $93,231 - $169,720	16,414 Added 138.96%	28,226 $191,000
Q1 2023 May 09, 2023	BUY	$2.83 - $5.11 $31,118 - $56,189	10,996 Added 1347.55%	11,812 $59,000
Q3 2022 Nov 04, 2022	BUY	$13.96 - $19.67 $11,391 - $16,050	816 New	816 $11,000
Q1 2022 May 05, 2022	SELL	$6.55 - $17.42 $421,846 - $1.12 Million	-64,404 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$15.51 - $29.31 $436,203 - $824,314	28,124 Added 77.52%	64,404 $1.04 Million
Q3 2021 Nov 08, 2021	BUY	$27.47 - $37.31 $914,860 - $1.24 Million	33,304 Added 1119.09%	36,280 $1.04 Million
Q1 2021 May 10, 2021	BUY	$29.16 - $51.96 $86,780 - $154,632	2,976 New	2,976 $89,000
Q4 2020 Feb 08, 2021	SELL	$37.86 - $54.26 $149,660 - $214,489	-3,953 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$23.66 - $49.53 $93,527 - $195,792	3,953 New	3,953 $170,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.